Last close 2026-11-06
$3.62-45.97%
- Trades
- 5
- Buys
- 0
- Sells
- 5
- Est. volume
- $89K
- Late filings
- 0
- Avg cumulative vs SPY
- -44%5 scored buys, trade-date to today
Trades and price
Disclosed STLN trades by members of Congress on the stock's price. Tap or hover for names.
BuysSells
| Month | Buys | Sells | Close |
|---|---|---|---|
| Sep 2026 | 0 | 5 | $6.66 |
Buys and sells of STLN per month as a CSV, with the month's last weekly close.
Top holders
Ranked by number of trades in this ticker
All trades
5 of 5
Richard Blumenthal
Senate · D · CT
Sell·p$1K-15K
-42.7% vs SPY
STLNStarling Oncology, Inc. - Common Stock
Underlying Asset of Hedge Holdings LLC. Name change – previously reported as Oncology Institute, Inc. (TOI).
Richard Blumenthal
Senate · D · CT
Sell·p$1K-15K
-43.7% vs SPY
STLNStarling Oncology, Inc. - Common Stock
Underlying Asset of Magnifique LLC. Name change – previously reported as Oncology Institute, Inc. (TOI).
Richard Blumenthal
Senate · D · CT
Sell·p$15K-50K
-43.7% vs SPY
STLNStarling Oncology, Inc. - Common Stock
Underlying Asset of LarryMae Partners LLC. Name change – previously reported as Oncology Institute, Inc. (TOI).
Richard Blumenthal
Senate · D · CT
Sell·p$1K-15K
-44.5% vs SPY
STLNStarling Oncology, Inc. - Common Stock
Underlying Asset of Magnifique LLC. Name change – previously reported as Oncology Institute, Inc. (TOI).
Richard Blumenthal
Senate · D · CT
Sell·p$15K-50K
-44.5% vs SPY
STLNStarling Oncology, Inc. - Common Stock
Underlying Asset of LarryMae Partners LLC. Name change – previously reported as Oncology Institute, Inc. (TOI).
| Asset | Source | |||||||
|---|---|---|---|---|---|---|---|---|
Richard Blumenthal Senate · D · CT | Starling Oncology, Inc. - Common Stock Underlying Asset of Hedge Holdings LLC. Name change – previously reported as Oncology Institute, Inc. (TOI). | Sell·p | $1K-15K | 2026-09-23 | 2026-10-26 33d | -42.7% | ||
Richard Blumenthal Senate · D · CT | Starling Oncology, Inc. - Common Stock Underlying Asset of Magnifique LLC. Name change – previously reported as Oncology Institute, Inc. (TOI). | Sell·p | $1K-15K | 2026-09-22 | 2026-10-26 34d | -43.7% | ||
Richard Blumenthal Senate · D · CT | Starling Oncology, Inc. - Common Stock Underlying Asset of LarryMae Partners LLC. Name change – previously reported as Oncology Institute, Inc. (TOI). | Sell·p | $15K-50K | 2026-09-22 | 2026-10-26 34d | -43.7% | ||
Richard Blumenthal Senate · D · CT | Starling Oncology, Inc. - Common Stock Underlying Asset of Magnifique LLC. Name change – previously reported as Oncology Institute, Inc. (TOI). | Sell·p | $1K-15K | 2026-09-18 | 2026-10-26 38d | -44.5% | ||
Richard Blumenthal Senate · D · CT | Starling Oncology, Inc. - Common Stock Underlying Asset of LarryMae Partners LLC. Name change – previously reported as Oncology Institute, Inc. (TOI). | Sell·p | $15K-50K | 2026-09-18 | 2026-10-26 38d | -44.5% |